Seattle, WA 的 血液癌症 臨床試驗
18 項針對 血液癌症 的研究正在 Seattle（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- 還有 1 項
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
招募中1/2 期
- Fred Hutchinson Cancer Research Center, Seattle
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- Fred Hutchinson Cancer Research Center, Seattle
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
招募中觀察性研究
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
招募中1 期
- University of Washington, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
招募中歡迎健康志工
- Fred Hutch/University of Washington Cancer Consortium, Seattle
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Fred Hutchinson Cancer Research Center, Seattle
IVIG for Infection Prevention After CAR-T-Cell Therapy
招募中2 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
招募中1/2 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
招募中觀察性研究
- Seattle Childrens Hospital, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- University of Washington Medical Center, Seattle
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
招募中2 期歡迎健康志工
- Fred Hutchinson Cancer Centre, Seattle
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
招募中觀察性研究
- Swedish Cancer Institute, Seattle
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
招募中
- University of Washington, Seattle
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Seattle Children's Hospital, Seattle
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
其他城市的 血液癌症 試驗
- Houston, TX46 項研究
- New York City, NY26 項研究
- Boston, MA25 項研究
- Washington, DC19 項研究
- Baltimore, MD18 項研究
- Los Angeles, CA17 項研究
- Durham, NC16 項研究
- Chicago, IL15 項研究
- Philadelphia, PA14 項研究
- Atlanta, GA13 項研究
- Nashville, TN13 項研究
- Edison, NJ13 項研究
Seattle 的其他研究
- 非小細胞肺癌53 項研究
- 癌症（所有類型）49 項研究
- 前列腺癌42 項研究
- 急性髓系白血病40 項研究
- 乳癌39 項研究
- 轉移性癌症39 項研究
- 大腸直腸癌34 項研究
- 肺癌33 項研究
- 卵巢癌30 項研究
- 多發性骨髓瘤22 項研究
- 骨髓增生異常症候群21 項研究
- 急性淋巴母細胞性白血病21 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。